MBC Biolabs

08/09/2023

The mural for our newest facility at 135 Mississippi Street, San Francisco looks absolutely incredible. Thank you for bringing our vision to life! 🧬

01/11/2023

Happy New Year! 🎉

Kicking off 2023 with our Golden Ticket celebrations as we announce the winners of last year's Diversity Golden Ticket, supported by AbbVie AND the Astellas Pharma Future Innovator Prize! Check out our January Newsletter to learn more about these incredible companies and other exciting news! 👉🏼 https://mbcbiolabs.com/newsletters-2023/newsletter-january-2023/

Here's to another year of enabling awesome! 🥂

12/09/2022

We are so proud to announce the winners of the MBC BioLabs Diversity Golden Ticket, supported by AbbVie: MabSwitch and NeuroAge Therapeutics! We cannot wait for these amazing companies to join our growing community!

Pictured: Yemi Onakunle, Co-founder and CEO of MabSwitch &
Christina Glorioso and Priyanka Joshi, Co-founders of NeuroAge

"MabSwitch, Inc is a biotechnology company that utilizes a proprietary universal allosteric-linker and switch module for antibodies (UNASMA-TM) technology to develop regulatable next-generation antibody-based immunotherapies such as switchable affinity T-Cell Engagers (SaefTE-TM) and switchable affinity CAR (SaefCAR-TM) T-cell therapies that are safer and more effective for the curative treatment of cancer and other devastating chronic diseases of significantly unmet medical need.”

“NeuroAge Therapeutics is a San Francisco based longevity biotech startup that creates drugs using our aging clock based platform to rejuvenate the brain and treat neurodegenerative disorders, including Alzheimer's disease. Unlike many other pharma companies that have targeted amyloid plaques and tangles, we target the number one cause of these disorders, aging. We have more than 25 years of experience from top institutions (MIT, Cambridge U., UC Berkeley), have been awarded an Illumina Sequencing grant, and are finalists in the National Institute on Aging Startup Challenge.”

12/02/2022

As another year approaches an end, we would like to share some highlights that made 2022 another special year! Check out our year at a glance! ✨
🎄 https://mbcbiolabs.com/newsletters-2022/newsletter-december-2022/ 🎄

Newsletter December 2022 IN THE NEWS Most Admired CEOs: Rachel Haurwitz of Caribou Biosciences Featured in San Francisco Business Times ► READ MORE Amplifying samples to boost sensitivity of UTI tests: BioAmp, USA The Longitude Prize ► READ MORE BigHat, cherry-picking opportunities amid stormy m...

11/01/2022

🎃 Candies, costumes, contests, food and a whole lot of fun! Happy Halloween Everyone! 🎃

09/19/2022

🍾 Another champagne celebration for experiments done on the first day in our labs! This time, we celebrated with Dispatch Bio who started at MBC BioLabs San Francisco just last week! Congratulations and welcome to the family, Dispatch Bio! 🥂

09/19/2022

The Astellas Future Innovator Prize 2022 competition is now open!

Apply today to accelerate your biotech innovation in MBC Biolabs state-of-the-art . The winner will gain one lab bench and research instrument access for one year at MBC BioLabs as well as access to Astellas’ R&D scientists, mentors, business leaders, and the Astellas network.

Click here to learn more:
www.astellas.com/en/astellasfutureinnovator/

09/14/2022

Our Founders at Work Series are back by popular demand! Learn about our founders and their experiences while enjoying some lunch with fellow scientists! Please join us next Thursday, September 22nd at 11:30 AM to learn more about gut mining for small molecule therapeutics with Kareem Barghouti, Cofounder and CEO of VastBiome. RSVP here: https://mbcbiolabs.com/mbc-biolab-event/mining-the-gut-for-small-molecule-therapeutics/

07/29/2022

So honored to have Mayor visit MBC BioLabs and see the amazing work our resident scientists have been doing! Thank you so much for your time and support Mayor Breed!

07/21/2022

ONO and MBC BioLabs are delighted to announce Weatherwax Biotechnologies as the winner of their “2022 Golden Ticket Competition”. The award supports entrepreneurial scientists and emerging biotechnology start-ups to accelerate early drug discovery and innovation for the potential future benefit of patients worldwide.
Congratulations, Weatherwax Bio! 🎉

07/20/2022

Our first STEM fest participation in the books! Here's a few photos from Portrero’s Hills Stem Fest last Saturday - we had so much fun being a part of this wonderful event! Thank you to our wonderful scientists for volunteering and curating an awesome science-filled experience for these curious minds! We can’t wait for next year!

07/19/2022

BMS and MBC BioLabs Announce 2022 Golden Ticket Competition!
The Bristol Myers Squibb Golden Ticket Contest at MBC BioLabs is a contest that awards 2 lab benches for 1 year to 2 innovative start-ups pursuing research in the fields of oncology, hematology, immunoscience, cardiovascular disease, neuroscience or fibrotic diseases that best meet the judging criteria.
Learn More and Apply Here: https://mbcbiolabs.com/featured/bristol-myers-squibb-golden-ticket-2022/